In honesty... too soon to tell. But understanding how penny stock capitalize using the types of lendors/speculators that actually lend to penny companies has told me that I smell something in the works with those 20bil shares. Is it a real attempt at making a legit company or a scam I just don't know. What I do know is that IMAI operates just like a baby Mina Mar and they put deals together. IMAI has announced to seek out joint ventures with it's new partner APHY in the pain management and MMJ industries. The thing I find very interesting going through the filings of APHY it that there is some serious names of willing lendors and speculators associated with this company. There is the smell of money behind APHY and you would do well to read about them. APHY has somehow managed to employ this guy Michael Mapes – Chief Compliance & Security Officer. This guy is no joke, he is a lobbyist no doubt and you need to become familiar with him, to understand the strength in a partnership with APHY http://www.linkedin.com/pub/mike-mapes/4/352/50 My suspicion is that it was the lendor/speculators that put him there. Issuing of 20 bil shares and then dead quiet from HESG means what? One possiblility is that the 20 bil shares were made in anticipation of converting them to Series A and B shares to be locked up for a time period usually 3 years and issued to lendors/speculators in exchange for funding. I can't tell you HESG will be picked up by IMAI or APHY or all these clues we have mean anything at all. This may just be another trail of bread crums that leads to another P&D for HESG. But I can tell you this IMO, APHY is a serious company with some serious players. This should not be ingnored.